No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adjuvants, Immunologic / pharmacology
-
Adjuvants, Immunologic / therapeutic use
-
Animals
-
Arthritis, Experimental / drug therapy
-
Arthritis, Experimental / etiology
-
Arthritis, Experimental / immunology
-
Arthritis, Experimental / therapy
-
Arthritis, Rheumatoid / immunology*
-
Arthritis, Rheumatoid / therapy
-
Autoimmune Diseases / immunology*
-
Autoimmune Diseases / therapy
-
Cytokines / physiology
-
Disease Models, Animal
-
Drug Evaluation, Preclinical
-
Galactosylceramides / pharmacology
-
Galactosylceramides / therapeutic use
-
Glycolipids / pharmacology
-
Glycolipids / therapeutic use
-
Humans
-
Immunotherapy, Adoptive
-
Killer Cells, Natural / drug effects
-
Killer Cells, Natural / immunology*
-
Killer Cells, Natural / transplantation
-
Lymphocyte Activation / drug effects
-
Mice
-
Mice, Inbred C57BL
-
Receptors, Antigen, T-Cell, alpha-beta / analysis
-
Receptors, Neurokinin-1 / analysis
-
T-Lymphocyte Subsets / drug effects
-
T-Lymphocyte Subsets / immunology*
-
T-Lymphocyte Subsets / transplantation
-
Transforming Growth Factor beta / physiology
-
Transforming Growth Factor beta1
Substances
-
Adjuvants, Immunologic
-
Cytokines
-
Galactosylceramides
-
Glycolipids
-
Receptors, Antigen, T-Cell, alpha-beta
-
Receptors, Neurokinin-1
-
TGFB1 protein, human
-
Tgfb1 protein, mouse
-
Transforming Growth Factor beta
-
Transforming Growth Factor beta1
-
alpha-galactosylceramide
-
tetracosanoic acid 1-galactopyranosyloxy-3,4-dihydroxydec-2-yl amide